Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Wells Fargo has recently downgraded its investment rating for cell therapy company ARCELLX, INC. from "Overweight" to "Equal Weight".

Wells Fargo has recently downgraded its investment rating for cell therapy company ARCELLX, INC. from "Overweight" to "Equal Weight".

老虎证券老虎证券2026/02/24 10:53
Show original
However, the institution has simultaneously raised the target stock price from $100 to $115, demonstrating recognition of the company's long-term value. This rating adjustment reflects the analysts' balanced consideration between short-term risks and long-term potential. The upward revision of the target price may be based on ARCELLX's technological advancements in the CAR-T cell therapy field or positive signals from clinical trial data.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Meta (META.US) data center's first high-yield bond is oversubscribed more than four times, strong demand drives premium issuance

The first junk bond issuance by the data center division of Meta Platforms attracted demand over four times the transaction size, with its enticing yields drawing in investors.

智通财经2026/09/19 04:11